LSX Nordic Congress 2023 | LSX - The Network For Life Science Executives | 9 October 2023 | Bella Sky, Center Blvd. 5, 2300 Copenhagen, DK

The event is connecting life science and healthcare industry leaders with international investment and strategic partners to further the growth, development and internationalisation of life science and healthcare innovation. Facilitate ever greater international investment into the region, as well as foster strategic partnerships and collaboration with key international healthcare stakeholders.

Why you should attend:
• Focusses almost exclusively on 3 main profiles – Biotech, Medtech and Healthtech CEOs, investors, and large pharma and medtech companies. That means our delegation is extremely focussed, extremely relevant and perfectly matched for partnering and investment.
• Offers access to more qualified life science investors than any event in the region. In 2023 will be bringing over 150 of the world’s most active investors to Copenhagen. Fundraising? There’s no better place to be.
• A highly sophisticated, easy to use and widely adopted 1-2-1 partnering platform. All our attendees are highly qualified and available to contact via a huge range of search criteria. Other events say they do ‘partnering’. We’re the experts at it.
• A 9 year track record of building communities and running events across the world. We have an unrivalled global network of CEOs, investors and pharma and we’ve been bringing the very best of them to the Nordic region for the last 6 years.
• As partnering, content, showcases and exhibition, LSX Nordic offers a range of smaller group meetings/CEO forums/workshops targeting particular profiles of attendees. This means highly qualified groups of attendees to meet in an interactive and intimate setting and provides you with the opportunity to talk to the people that matter most to you.

2023 Speakers

Keld Flintholm Jørgensen
EVP & CBO, Lundbeck

Emelie Antoni
Country President, Nordic & Sweden, AstraZeneca

Nathalie ter Wengel
European Lead Worldwide Business Development, Pfizer

Jennifer Laird
VP, S&E, Eli Lilly

Adam Kostyal
SVP, Head Listings EMEA, Nasdaq

Malin Johansson
Global Head of Digital Health Partnerships, Novo Nordisk

Charlotte Søby Vestergaard
Global Head of Digital Markets, Sanofi

Beth Wolff
Director Digital Health Solutions, Global Corporate Strategy & BD, Lundbeck

Frederik Knud Nielsen
Healthcare Partnership Director, Novartis

Kim Baden-Kristensen
CEO & Co-founder, Brain+

Jonathan Gertler
CEO, Back Bay Life Science Advisors; MD, BioVentures MedTech Funds

Tejas Atawane
Head of Business Development, Philips

Bo Vendelboe
VP, Business Transformation & Commercial Excellence EMEA, Zimmer Biomet

Emily Xiao Fu
M&A Director, Halma

Linn Christensson
General Manager Nordics, Benelux, Zimmer Biomet

Jeroen Bakker
Principal Seed Investment, Novo Holdings

2023 Sponsors and Partners

PLATINUM PARTNERS
• DNB Backbay
• Nasdaq

GOLD PARTNERS:
• Coulter Partners
• Mintz
• NDA Group

LOCAL HOST PARTNERS:
• BioInnovation Institute (BII)
• Lundbeckfonden
• Novo Nordisk Fonden

SILVER PARTNERS:
• AWA Patent
• MSC Nordics 3
• Sterne Kessler

BRONZE PARTNERS:
• Biobridge
• GenScript Biotech
• porton pharma solutions
• OPIS

INTERNATIONAL INVESTOR SPONSORS:
• Ministry of Foreign Affairs of Denmark
• EIFO

SUPPORTING PARTNERS:
• Argentum
• BioPartner
• Copenhagen Capacity
• Dansk Biotek
• FemTech Lab
• Freemind
• Medicon Valley Alliance 2022
• Medicon Village
• MEDiSTRAVA Consulting
• Medtech Bridge
• Nordic Health Lab
• Optimum Communications
• RHA Communications